Enterolactone and THBS1‐3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironment
ENL has potent inhibitory effects on ovarian cancer and suppresses malignant angiogenesis by binding to THBS1-3TSR. ENL ameliorates gut dysbacteriosis.
Authors
- Yufan Zhao (ORCID: https://orcid.org/0009-0008-2356-5131)
- Huidi Liu (ORCID: https://orcid.org/0000-0002-1884-0898)
- Yiping Guo (ORCID: https://orcid.org/0000-0003-0251-450X)
- Mengzhi Xu (ORCID: https://orcid.org/0000-0002-0400-3191)
- Jiayu Wei
- Lin Chen (ORCID: https://orcid.org/0000-0002-8233-800X)
- Zhaocong Zhang
- Danli Cao (ORCID: https://orcid.org/0000-0002-9859-3013)
- Xin Kang (ORCID: https://orcid.org/0000-0002-4735-1049)
- Yingying Zhang (ORCID: https://orcid.org/0000-0001-8794-364X)
- Xinghua Zhang (ORCID: https://orcid.org/0000-0003-0174-5410)
- Shimenghui Deng
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Shuhui Chai
- Yu Yan
- Jinying Yang
- Yuxue Shi
- Zhiyi Yuan
- Ling Jie Luo
- Shu‐Lin Liu
- Gui‐Rong Liu
Institutions
- Harbin Medical University (CN)
- University of Calgary (CA)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Heilongjiang Provincial Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1111/bph.70327
- Primary Topic
- Digestive system and related health
- Type
- article
- Field-Weighted Citation Impact
- 0.00